The comparative efficacy of therapy with typical and atypical antipsychotics
Tsygankov, B.D.; Agasarian, E.G.
Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 110(9): 83-86
2010
ISSN/ISBN: 1997-7298 PMID: 21246901 Document Number: 639948
Document emailed within 1 workday
Related Documents
Czekalla, J.; Kollack-Walker, S.; Beasley, C.M. 2001: Cardiac safety parameters of olanzapine: comparison with other atypical and typical antipsychotics Journal of Clinical Psychiatry 62(Suppl): 35-40Puri, B.K.; Davey, N.J.; Zaman, R. 2003: Excitability of the motor cortex in schizophrenia following typical and atypical antipsychotics: two serial case reports International Journal of Clinical Practice 57(9): 831-833
Hrdlicka, M.; Zedkova, I.; Blatny, M.; Urbanek, T. 2009: Weight gain associated with atypical and typical antipsychotics during treatment of adolescent schizophrenic psychoses: A retrospective study Neuro Endocrinology Letters 30(2): 256-261
Arsen'eva, T.E.; Lebedeva, S.A.; Trukhachev, A.L.; Vasil'eva, E.A.; Ivanova, V.S.; Bozhko, N.V. 2010: Comparison of efficacy of tests for differentiation of typical and atypical strains of Yersinia pestis and Yersinia pseudotuberculosis Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 75-81
Ohmori, T. 2013: Pharmacology and clinical implication of typical antipsychotics Nihon Rinsho. Japanese Journal of Clinical Medicine 71(4): 648-653
Shoshina, I.I.; Shelepin, I.E.; Semenova, N.B. 2014: The frequency-contrast sensitivity of visual stimulus perception in patients with schizophrenia with the therapy of atypical and typical antipsychotic drugs Fiziologiia Cheloveka 40(1): 43-48
Arana, G.W. 2000: An overview of side effects caused by typical antipsychotics Journal of Clinical Psychiatry 61(Suppl 8): 5
Glazer, W.M. 2000: Review of incidence studies of tardive dyskinesia associated with typical antipsychotics Journal of Clinical Psychiatry 61(Suppl): 15-20
Armer, R.; Miller, D.J. 2000: Recent advances in atypical antipsychotics Current Opinion in Investigational Drugs 1(4): 481-493
Farver, D. 2007: The outpatient use of atypical antipsychotics with Alzheimer's disease South Dakota Medicine: the Journal of the South Dakota State Medical Association 60(3): 113; 115
Frecska, E. 2005: From cradle to grave? Expectations from atypical antipsychotics Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 7(1): 34-38
Rollini, M.; Schulz, P. 2008: Atypical antipsychotics for elderly patients: to prescribe or to ban? Revue Medicale Suisse 4(153): 979
Findling, R.L. 2004: Atypical antipsychotics in the treatment of children and adolescents Journal of Clinical Psychiatry 65(Suppl): 3-4
Haberfellner, E.M.; Honsig, T. 2003: Nonalcoholic steatohepatitis: a possible side effect of atypical antipsychotics Journal of Clinical Psychiatry 64(7): 851
Glazer, W.M. 2000: Expected incidence of tardive dyskinesia associated with atypical antipsychotics Journal of Clinical Psychiatry 61(Suppl): 21-26
Splinter, G.; Nesser, N. 2012: OHCA supports docs with best practice for atypical antipsychotics Journal of the Oklahoma State Medical Association 105(8): 324-325
Duggins, R.; Rhinds, D.; Hall, W. 2001: Atypical antipsychotics in the treatment of schizophrenia. Cost is a crucial issue Bmj 322(7291): 926; Author Reply 927-8
Omori, T. 2001: Efficacy of atypical antipsychotic agents for maintenance therapy of schizophrenia Seishin Shinkeigaku Zasshi 103(6): 470-475
Taylor, D. 2001: Atypical antipsychotics in the treatment of schizophrenia. Pragmatic considerations are important when considering which drug to prescribe Bmj 322(7291): 925; Author Reply 927-8
Drummond, M..F..; Knapp, M..R.J..; Burns, T..P..; Shadwell, P.. 1998: Issues in the design of studies for the economic evaluation of new atypical antipsychotics: the ESTO study Journal of Mental Health Policy and Economics 1(1): 15-22